Genetic diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM)

Netherlands Heart Journal

Volumn 18, Issue 3, 2010, Pages 144-162

  Van Langen, I M ^a   Arens, Y ^b   Baars, H ^c   Bokenkamp, R ^d   Delhaas, T ^b   Dooijes, D ^e   Lekanne Deprez, R ^f   Majoor Krakauer, D ^g   Ten Cate, F J ^g   Michels, M ^g   Van Mil, A ^d   Pinto, Y ^f   Schiphorst, A ^f   Van Der Smagt, J J ^e   Van Tintelen, J P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LUMC ^*

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

DEFIBRILLATOR; GENETIC COUNSELING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; LABORATORY TEST; OUTPATIENT DEPARTMENT; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; SOCIAL PSYCHOLOGY;

EID: 77949576119     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03091753     Document Type: Review

References (28)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J. 2008;29:270-6.
2. Morita H, Larson MG, Barr SC, Vasan RS, O'Donnell CJ, Hirschhorn JN, et al. Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation. 2006;113:2697-705.
3. Hurst JA, Firth HV, Hall JG. Hypertrophic cardiomyopathy. In Oxford Desk Reference Clinical Genetics, Oxford University Press, USA, 2005; pp. 360-2.
4. Charron P, Heron D, Gargiulo M, Richard P, Dubourg O, Desnos M,et al. Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. J Med Genet. 2002;39:741-6.
5. Smets EMA, Stam MMH, Meulenkamp TM, van Langen IM, Wilde AAM, Wiegman A, et al. Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am J Med Genet A. 2008;146:700-7.
6. Hoedemaekers E, Jaspers JP, Van Tintelen JP. The influence of coping styles and perceived control on emotional distress in persons at risk for a hereditary heart disease. Am J Med Genet A. 2007;143:1997-2005.
7. Hendriks KS, Hendriks MM, Birnie E, Grosfeld FJ, Wilde AA, van den Bout J, et al. Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm. 2008;5:719-24.
8. Hendriks KS, Grosfeld FJ, Wilde AA, van den Bout J, van Langen IM, van Tintelen JP, et al. High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet. 2005;8:103-13.
9. Hendriks KS, Grosfeld FJ, van Tintelen JP, van Langen IM, Wilde AA, van den Bout J, et al. Can parents adjust to the idea that their child is at risk for a sudden death? Psychological impact of risk for long QT syndrome. Am J Med Genet A. 2005;138:107-12
10. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:1903-10
11. Lekanne Deprez RH, Muurling-Vlietman JJ, Hruda J, Baars MJ, Wijnaendts LC, et al. Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene. J Med Genet. 2006;43:829-32.
12. Richard P, Villard E, Charron P, Isnard R. The genetic bases of cardiomyopathies. JACC 2006;48 (suppl A):79-89.
13. Ho CY, Seidman CE. Contemporary approach to HCM. Circulation. 2006;113:e858-62.
14. Van Driest SL, Ommen SR, Tajik AJ, Gersch BJ, Ackerman MJ. Sarcomeric genotyping in Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2005;80:463-9.
15. Alders M, Jongbloed R, Deelen W, van den Wijngaard A, Doevendans P, Ten Cate F, et al. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J. 2003;24:1848-53.
16. Guideline on predictive DNA testing, Vereniging Klinische Genetica Nederland, the Netherlands, January 2007.
17. Hermans JF, Christiaans I, van Tintelen JP, Wilde AAM, Pinto YM. GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J 2006;14:272.
18. Cox GF, Sleeper LA, Lowe AM, et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 2006;118:1519-31.
19. Colan SD, Lipschutz E, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Circulation. 2007;115:773-81.
20. Nugent AW, Daubeney PEF, Chaondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:16399-46.
21. Schwartz ML, Cox, GF, Lin AE, et al. Clinical approach to genetic cardiomyopathy in children. Circulation. 1996;94:2121-38.
22. Van Langen IM, Birnie E, Schuurman E, Tan HL, Hofman N, Bonsel GJ, et al. Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet. 2005;68:360-8.
23. McKenna WJ. Diagnostic criteria for hypertrophic cardiomyopathy in adult members of affected families. Heart. 1997;77:130-2.
24. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003;24:1965-91.
25. Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy, Magn Reson Imaging. 2004;22:901.
26. Cobben JM, Brocker-Vriends AH, Leschot NJ. Prenatal diagnosis for hereditary predisposition to mammary and ovarian carcinoma - defining a position, Ned Tijdschr Geneeskd. 2002;146:1461-5.
27. Charron P, Heron D, Gargiulo M, Feingold J, Oury JF, Richard P, et al. Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case. Prenat Diagn. 2004;24:701-3.
28. Michels M, Hoedemakers YM, Kofflard MJ, Frohn-Mulder I, Dooijes D, Majoor-Krakauer D, et al. Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J. 2007;15:184-90.